| Date Filed | Type | Description |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/19/2023 |
4
| RICHINS PAUL O (Director) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Sold 700 shares
@ $93.47, valued at
$65.4k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/25/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/28/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/17/2023 |
4
| RICHINS PAUL O (Director) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Gifted 150 shares
@ $92.5, valued at
$13.9k
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
4
| PAYNE BARBARA A (Director) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Gifted 500 shares
@ $89.9974, valued at
$45k
|
|
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 10.5% stake in UTAH MEDICAL PRODUCTS INC |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 4.6% stake in Utah Medical Products Inc. |
| 01/31/2023 |
8-K
| Quarterly results |
| 12/06/2022 |
4
| Koopman Brian (Principal Financial Officer) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Paid exercise price by delivering 366 shares
@ $101.88, valued at
$37.3k
Exercised 500 options to buy
@ $74.64, valued at
$37.3k
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
4
| Koopman Brian (Principal Financial Officer) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Gifted 65 shares
@ $88.94, valued at
$5.8k
|
|
| 11/01/2022 |
8-K
| Quarterly results |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/27/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 06/27/2022 |
4
| RICHINS PAUL O (Director) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Gifted 250 shares
@ $88.98, valued at
$22.2k
|
|
| 06/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/31/2022 |
SD
| Form SD - Specialized disclosure report: |
| 05/11/2022 |
4
| PAYNE BARBARA A (Director) has filed a Form 4 on UTAH MEDICAL PRODUCTS INC|
Txns:
| Sold 2,000 shares
@ $85.1983, valued at
$170.4k
|
|
| 05/11/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|